サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1122883

世界の多嚢胞性卵巣症候群治療市場：考察と予測 (2028年まで)

Global Polycystic Ovarian Syndrome Treatment Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 101 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の多嚢胞性卵巣症候群治療市場：考察と予測 (2028年まで)
出版日: 2022年09月07日
発行: QYResearch
ページ情報: 英文 101 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、多嚢胞性卵巣症候群治療 (Polycystic Ovarian Syndrome Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の多嚢胞性卵巣症候群治療の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Oral Contraceptives
    • Insulin Sensitizing Agents
    • Anti-Depressants
    • Ornithine
    • Decarboxylase Inhibitors
    • Aromatase Inhibitors and SERMs
    • Diuretics
  • 市場：アプリケーション別
    • 世界の多嚢胞性卵巣症候群治療の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospital Pharmacies
    • Drug Stores
    • E-Commerce
    • Fertility Clinics
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の多嚢胞性卵巣症候群治療の市場展望 (2017-2028)
  • 多嚢胞性卵巣症候群治療の市場成長トレンド：地域別
    • 多嚢胞性卵巣症候群治療 市場規模：地域別: 2017 VS 2021 VS 2028
    • 多嚢胞性卵巣症候群治療の市場規模実績：地域別 (2017-2022)
    • 多嚢胞性卵巣症候群治療の市場規模予測：地域別 (2023-2028)
  • 多嚢胞性卵巣症候群治療 市場動向
    • 多嚢胞性卵巣症候群治療 業界動向
    • 多嚢胞性卵巣症候群治療 市場の促進要因
    • 多嚢胞性卵巣症候群治療 市場の課題
    • 多嚢胞性卵巣症候群治療 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の多嚢胞性卵巣症候群治療の上位企業：収益別
    • 世界の多嚢胞性卵巣症候群治療の上位企業：収益別 (2017-2022)
    • 世界の多嚢胞性卵巣症候群治療の収益シェア：企業別 (2017-2022)
  • 世界の多嚢胞性卵巣症候群治療の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：多嚢胞性卵巣症候群治療の収益
  • 世界の多嚢胞性卵巣症候群治療 市場集中度
    • 世界の多嚢胞性卵巣症候群治療 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 多嚢胞性卵巣症候群治療の収益 2021
  • 多嚢胞性卵巣症候群治療の主要企業の本社および事業エリア
  • 主要企業 多嚢胞性卵巣症候群治療の製品ソリューションおよびサービス
  • 市場参入時期： 多嚢胞性卵巣症候群治療 市場
  • M&A, 拡張計画

第4章 多嚢胞性卵巣症候群治療 内訳データ：タイプ別

  • 世界の多嚢胞性卵巣症候群治療の市場規模実績：タイプ別 (2017-2022)
  • 世界の多嚢胞性卵巣症候群治療の市場規模予測：タイプ別 (2023-2028)

第5章 多嚢胞性卵巣症候群治療 内訳データ：アプリケーション別

  • 世界の多嚢胞性卵巣症候群治療の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の多嚢胞性卵巣症候群治療の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の多嚢胞性卵巣症候群治療 市場規模 (2017-2028)
  • 北米の多嚢胞性卵巣症候群治療 市場規模：タイプ別
    • 北米の多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2017-2022)
    • 北米の多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2023-2028)
    • 北米の多嚢胞性卵巣症候群治療の市場シェア：タイプ別 (2017-2028)
  • 北米の多嚢胞性卵巣症候群治療 市場規模：アプリケーション別
    • 北米の多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2017-2022)
    • 北米の多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2023-2028)
    • 北米の多嚢胞性卵巣症候群治療の市場シェア：アプリケーション別 (2017-2028)
  • 北米の多嚢胞性卵巣症候群治療 市場規模：国別
    • 北米の多嚢胞性卵巣症候群治療 市場規模：国別 (2017-2022)
    • 北米の多嚢胞性卵巣症候群治療 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の多嚢胞性卵巣症候群治療 市場規模 (2017-2028)
  • 欧州の多嚢胞性卵巣症候群治療 市場規模：タイプ別
    • 欧州の多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2017-2022)
    • 欧州の多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2023-2028)
    • 欧州の多嚢胞性卵巣症候群治療の市場シェア：タイプ別 (2017-2028)
  • 欧州の多嚢胞性卵巣症候群治療 市場規模：アプリケーション別
    • 欧州の多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2017-2022)
    • 欧州の多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2023-2028)
    • 欧州の多嚢胞性卵巣症候群治療の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の多嚢胞性卵巣症候群治療 市場規模：国別
    • 欧州の多嚢胞性卵巣症候群治療 市場規模：国別 (2017-2022)
    • 欧州の多嚢胞性卵巣症候群治療 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模 (2017-2028)
  • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：タイプ別
    • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 多嚢胞性卵巣症候群治療の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：アプリケーション別
    • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 多嚢胞性卵巣症候群治療の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：地域別
    • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 多嚢胞性卵巣症候群治療 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模 (2017-2028)
  • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：タイプ別
    • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの多嚢胞性卵巣症候群治療の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：アプリケーション別
    • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの多嚢胞性卵巣症候群治療の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：国別
    • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：国別 (2017-2022)
    • ラテンアメリカの多嚢胞性卵巣症候群治療 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模 (2017-2028)
  • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：タイプ別
    • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの多嚢胞性卵巣症候群治療の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：アプリケーション別
    • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの多嚢胞性卵巣症候群治療の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：国別
    • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：国別 (2017-2022)
    • 中東・アフリカの多嚢胞性卵巣症候群治療 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Sanofi
  • Novartis
  • Teva Pharmaceutical Industries
  • Merck
  • AstraZeneca

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Polycystic Ovarian Syndrome Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Oral Contraceptives
  • Table 3. Key Players of Insulin Sensitizing Agents
  • Table 4. Key Players of Anti-Depressants
  • Table 5. Key Players of Ornithine
  • Table 6. Key Players of Decarboxylase Inhibitors
  • Table 7. Key Players of Aromatase Inhibitors and SERMs
  • Table 8. Key Players of Diuretics
  • Table 9. Global Polycystic Ovarian Syndrome Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 10. Global Polycystic Ovarian Syndrome Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 11. Global Polycystic Ovarian Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 12. Global Polycystic Ovarian Syndrome Treatment Market Share by Region (2017-2022)
  • Table 13. Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 14. Global Polycystic Ovarian Syndrome Treatment Market Share by Region (2023-2028)
  • Table 15. Polycystic Ovarian Syndrome Treatment Market Trends
  • Table 16. Polycystic Ovarian Syndrome Treatment Market Drivers
  • Table 17. Polycystic Ovarian Syndrome Treatment Market Challenges
  • Table 18. Polycystic Ovarian Syndrome Treatment Market Restraints
  • Table 19. Global Polycystic Ovarian Syndrome Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 20. Global Polycystic Ovarian Syndrome Treatment Revenue Share by Players (2017-2022)
  • Table 21. Global Top Polycystic Ovarian Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Ovarian Syndrome Treatment as of 2021)
  • Table 22. Ranking of Global Top Polycystic Ovarian Syndrome Treatment Companies by Revenue (US$ Million) in 2021
  • Table 23. Global 5 Largest Players Market Share by Polycystic Ovarian Syndrome Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 24. Key Players Headquarters and Area Served
  • Table 25. Key Players Polycystic Ovarian Syndrome Treatment Product Solution and Service
  • Table 26. Date of Enter into Polycystic Ovarian Syndrome Treatment Market
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 29. Global Polycystic Ovarian Syndrome Treatment Revenue Market Share by Type (2017-2022)
  • Table 30. Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 31. Global Polycystic Ovarian Syndrome Treatment Revenue Market Share by Type (2023-2028)
  • Table 32. Global Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 33. Global Polycystic Ovarian Syndrome Treatment Revenue Share by Application (2017-2022)
  • Table 34. Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. Global Polycystic Ovarian Syndrome Treatment Revenue Share by Application (2023-2028)
  • Table 36. North America Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 37. North America Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 38. North America Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 39. North America Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 40. North America Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 41. North America Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 42. Europe Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 43. Europe Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 44. Europe Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 45. Europe Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 46. Europe Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 47. Europe Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 52. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 53. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 54. Latin America Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 55. Latin America Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 56. Latin America Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 57. Latin America Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 58. Latin America Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 59. Latin America Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 64. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 65. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 66. Sanofi Company Details
  • Table 67. Sanofi Business Overview
  • Table 68. Sanofi Polycystic Ovarian Syndrome Treatment Product
  • Table 69. Sanofi Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 70. Sanofi Recent Developments
  • Table 71. Novartis Company Details
  • Table 72. Novartis Business Overview
  • Table 73. Novartis Polycystic Ovarian Syndrome Treatment Product
  • Table 74. Novartis Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 75. Novartis Recent Developments
  • Table 76. Teva Pharmaceutical Industries Company Details
  • Table 77. Teva Pharmaceutical Industries Business Overview
  • Table 78. Teva Pharmaceutical Industries Polycystic Ovarian Syndrome Treatment Product
  • Table 79. Teva Pharmaceutical Industries Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 80. Teva Pharmaceutical Industries Recent Developments
  • Table 81. Merck Company Details
  • Table 82. Merck Business Overview
  • Table 83. Merck Polycystic Ovarian Syndrome Treatment Product
  • Table 84. Merck Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 85. Merck Recent Developments
  • Table 86. AstraZeneca Company Details
  • Table 87. AstraZeneca Business Overview
  • Table 88. AstraZeneca Polycystic Ovarian Syndrome Treatment Product
  • Table 89. AstraZeneca Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022) & (US$ Million)
  • Table 90. AstraZeneca Recent Developments
  • Table 91. Research Programs/Design for This Report
  • Table 92. Key Data Information from Secondary Sources
  • Table 93. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Polycystic Ovarian Syndrome Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Oral Contraceptives Features
  • Figure 3. Insulin Sensitizing Agents Features
  • Figure 4. Anti-Depressants Features
  • Figure 5. Ornithine Features
  • Figure 6. Decarboxylase Inhibitors Features
  • Figure 7. Aromatase Inhibitors and SERMs Features
  • Figure 8. Diuretics Features
  • Figure 9. Global Polycystic Ovarian Syndrome Treatment Market Share by Application: 2021 VS 2028
  • Figure 10. Hospital Pharmacies Case Studies
  • Figure 11. Drug Stores Case Studies
  • Figure 12. E-Commerce Case Studies
  • Figure 13. Fertility Clinics Case Studies
  • Figure 14. Polycystic Ovarian Syndrome Treatment Report Years Considered
  • Figure 15. Global Polycystic Ovarian Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 16. Global Polycystic Ovarian Syndrome Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 17. Global Polycystic Ovarian Syndrome Treatment Market Share by Region: 2021 VS 2028
  • Figure 18. Global Polycystic Ovarian Syndrome Treatment Market Share by Players in 2021
  • Figure 19. Global Top Polycystic Ovarian Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polycystic Ovarian Syndrome Treatment as of 2021)
  • Figure 20. The Top 10 and 5 Players Market Share by Polycystic Ovarian Syndrome Treatment Revenue in 2021
  • Figure 21. North America Polycystic Ovarian Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. North America Polycystic Ovarian Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 23. North America Polycystic Ovarian Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 24. North America Polycystic Ovarian Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 25. United States Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. Canada Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Europe Polycystic Ovarian Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 28. Europe Polycystic Ovarian Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 29. Europe Polycystic Ovarian Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 30. Europe Polycystic Ovarian Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 31. Germany Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. France Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. U.K. Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Italy Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Russia Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Nordic Countries Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 38. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 39. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 40. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Size Share by Region (2017-2028)
  • Figure 41. China Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Japan Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. South Korea Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. India Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Australia Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 47. Latin America Polycystic Ovarian Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Latin America Polycystic Ovarian Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 49. Latin America Polycystic Ovarian Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 50. Latin America Polycystic Ovarian Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 51. Mexico Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Brazil Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 54. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size Market Share by Type (2017-2028)
  • Figure 55. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size Market Share by Application (2017-2028)
  • Figure 56. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Size Share by Country (2017-2028)
  • Figure 57. Turkey Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Saudi Arabia Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 59. UAE Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 60. Sanofi Revenue Growth Rate in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
  • Figure 61. Novartis Revenue Growth Rate in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
  • Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
  • Figure 63. Merck Revenue Growth Rate in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
  • Figure 64. AstraZeneca Revenue Growth Rate in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed
目次

This research report focuses on the Polycystic Ovarian Syndrome Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Polycystic Ovarian Syndrome Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Oral Contraceptives
    • 1.2.3 Insulin Sensitizing Agents
    • 1.2.4 Anti-Depressants
    • 1.2.5 Ornithine
    • 1.2.6 Decarboxylase Inhibitors
    • 1.2.7 Aromatase Inhibitors and SERMs
    • 1.2.8 Diuretics
  • 1.3 Market by Application
    • 1.3.1 Global Polycystic Ovarian Syndrome Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Drug Stores
    • 1.3.4 E-Commerce
    • 1.3.5 Fertility Clinics
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Polycystic Ovarian Syndrome Treatment Market Perspective (2017-2028)
  • 2.2 Polycystic Ovarian Syndrome Treatment Growth Trends by Region
    • 2.2.1 Polycystic Ovarian Syndrome Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Polycystic Ovarian Syndrome Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Polycystic Ovarian Syndrome Treatment Market Dynamics
    • 2.3.1 Polycystic Ovarian Syndrome Treatment Industry Trends
    • 2.3.2 Polycystic Ovarian Syndrome Treatment Market Drivers
    • 2.3.3 Polycystic Ovarian Syndrome Treatment Market Challenges
    • 2.3.4 Polycystic Ovarian Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Polycystic Ovarian Syndrome Treatment Players by Revenue
    • 3.1.1 Global Top Polycystic Ovarian Syndrome Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Polycystic Ovarian Syndrome Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Polycystic Ovarian Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Polycystic Ovarian Syndrome Treatment Revenue
  • 3.4 Global Polycystic Ovarian Syndrome Treatment Market Concentration Ratio
    • 3.4.1 Global Polycystic Ovarian Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Polycystic Ovarian Syndrome Treatment Revenue in 2021
  • 3.5 Polycystic Ovarian Syndrome Treatment Key Players Head office and Area Served
  • 3.6 Key Players Polycystic Ovarian Syndrome Treatment Product Solution and Service
  • 3.7 Date of Enter into Polycystic Ovarian Syndrome Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Polycystic Ovarian Syndrome Treatment Breakdown Data by Type

  • 4.1 Global Polycystic Ovarian Syndrome Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Type (2023-2028)

5 Polycystic Ovarian Syndrome Treatment Breakdown Data by Application

  • 5.1 Global Polycystic Ovarian Syndrome Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Polycystic Ovarian Syndrome Treatment Market Size (2017-2028)
  • 6.2 North America Polycystic Ovarian Syndrome Treatment Market Size by Type
    • 6.2.1 North America Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Polycystic Ovarian Syndrome Treatment Market Share by Type (2017-2028)
  • 6.3 North America Polycystic Ovarian Syndrome Treatment Market Size by Application
    • 6.3.1 North America Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Polycystic Ovarian Syndrome Treatment Market Share by Application (2017-2028)
  • 6.4 North America Polycystic Ovarian Syndrome Treatment Market Size by Country
    • 6.4.1 North America Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Polycystic Ovarian Syndrome Treatment Market Size (2017-2028)
  • 7.2 Europe Polycystic Ovarian Syndrome Treatment Market Size by Type
    • 7.2.1 Europe Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Polycystic Ovarian Syndrome Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Polycystic Ovarian Syndrome Treatment Market Size by Application
    • 7.3.1 Europe Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Polycystic Ovarian Syndrome Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Polycystic Ovarian Syndrome Treatment Market Size by Country
    • 7.4.1 Europe Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Polycystic Ovarian Syndrome Treatment Market Size (2017-2028)
  • 9.2 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Type
    • 9.2.1 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Polycystic Ovarian Syndrome Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Application
    • 9.3.1 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Polycystic Ovarian Syndrome Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Country
    • 9.4.1 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Polycystic Ovarian Syndrome Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Details
    • 11.1.2 Sanofi Business Overview
    • 11.1.3 Sanofi Polycystic Ovarian Syndrome Treatment Introduction
    • 11.1.4 Sanofi Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
    • 11.1.5 Sanofi Recent Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Polycystic Ovarian Syndrome Treatment Introduction
    • 11.2.4 Novartis Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
    • 11.2.5 Novartis Recent Developments
  • 11.3 Teva Pharmaceutical Industries
    • 11.3.1 Teva Pharmaceutical Industries Company Details
    • 11.3.2 Teva Pharmaceutical Industries Business Overview
    • 11.3.3 Teva Pharmaceutical Industries Polycystic Ovarian Syndrome Treatment Introduction
    • 11.3.4 Teva Pharmaceutical Industries Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
    • 11.3.5 Teva Pharmaceutical Industries Recent Developments
  • 11.4 Merck
    • 11.4.1 Merck Company Details
    • 11.4.2 Merck Business Overview
    • 11.4.3 Merck Polycystic Ovarian Syndrome Treatment Introduction
    • 11.4.4 Merck Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
    • 11.4.5 Merck Recent Developments
  • 11.5 AstraZeneca
    • 11.5.1 AstraZeneca Company Details
    • 11.5.2 AstraZeneca Business Overview
    • 11.5.3 AstraZeneca Polycystic Ovarian Syndrome Treatment Introduction
    • 11.5.4 AstraZeneca Revenue in Polycystic Ovarian Syndrome Treatment Business (2017-2022)
    • 11.5.5 AstraZeneca Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer